Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma

ABSTRACTAlternative splicing is a process causing mRNA translation to produce different proteins, and it is crucial for the development of tumours. In this study, we constructed a prognostic model related to alternative splicing events in hepatocarcinoma using bioinformatics analysis, including the...

Full description

Bibliographic Details
Main Authors: Zhenyi Lv, Wenqi Gao, Zhiwei Du, Yi Zheng, Tianming Liu, Chenjun Hao, Dongbo Xue
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Epigenetics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15592294.2023.2276371
_version_ 1797635967844089856
author Zhenyi Lv
Wenqi Gao
Zhiwei Du
Yi Zheng
Tianming Liu
Chenjun Hao
Dongbo Xue
author_facet Zhenyi Lv
Wenqi Gao
Zhiwei Du
Yi Zheng
Tianming Liu
Chenjun Hao
Dongbo Xue
author_sort Zhenyi Lv
collection DOAJ
description ABSTRACTAlternative splicing is a process causing mRNA translation to produce different proteins, and it is crucial for the development of tumours. In this study, we constructed a prognostic model related to alternative splicing events in hepatocarcinoma using bioinformatics analysis, including the alternative splicing of CSAD, AFMID, ZDHHC16, and IRF3. The model is an independent prognostic factor and can accurately predict a patient’s prognosis. IRF3 is a transcription factor related to the immune response. Its alternative splicing can affect the expression of various genes related to prognosis and plays an essential role in the tumour microenvironment. We also verified the expression of IRF3 exon skipping isoform in hepatocarcinoma at the mRNA level. In conclusion, we discovered that the alternative splicing of IRF3 is essential for the development of hepatocarcinoma. This study provides new insight into the development of treatments for hepatocarcinoma.
first_indexed 2024-03-11T12:28:06Z
format Article
id doaj.art-5c99ede2c10841dca7a5a164daf4e0cc
institution Directory Open Access Journal
issn 1559-2294
1559-2308
language English
last_indexed 2024-03-11T12:28:06Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj.art-5c99ede2c10841dca7a5a164daf4e0cc2023-11-06T05:37:16ZengTaylor & Francis GroupEpigenetics1559-22941559-23082023-12-0118110.1080/15592294.2023.2276371Alternative splicing of IRF3 plays an important role in the development of hepatocarcinomaZhenyi Lv0Wenqi Gao1Zhiwei Du2Yi Zheng3Tianming Liu4Chenjun Hao5Dongbo Xue6Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaKey Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaABSTRACTAlternative splicing is a process causing mRNA translation to produce different proteins, and it is crucial for the development of tumours. In this study, we constructed a prognostic model related to alternative splicing events in hepatocarcinoma using bioinformatics analysis, including the alternative splicing of CSAD, AFMID, ZDHHC16, and IRF3. The model is an independent prognostic factor and can accurately predict a patient’s prognosis. IRF3 is a transcription factor related to the immune response. Its alternative splicing can affect the expression of various genes related to prognosis and plays an essential role in the tumour microenvironment. We also verified the expression of IRF3 exon skipping isoform in hepatocarcinoma at the mRNA level. In conclusion, we discovered that the alternative splicing of IRF3 is essential for the development of hepatocarcinoma. This study provides new insight into the development of treatments for hepatocarcinoma.https://www.tandfonline.com/doi/10.1080/15592294.2023.2276371Alternative splicingexon skiphepatocellular carcinomaIRF3immune infiltration
spellingShingle Zhenyi Lv
Wenqi Gao
Zhiwei Du
Yi Zheng
Tianming Liu
Chenjun Hao
Dongbo Xue
Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
Epigenetics
Alternative splicing
exon skip
hepatocellular carcinoma
IRF3
immune infiltration
title Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
title_full Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
title_fullStr Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
title_full_unstemmed Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
title_short Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma
title_sort alternative splicing of irf3 plays an important role in the development of hepatocarcinoma
topic Alternative splicing
exon skip
hepatocellular carcinoma
IRF3
immune infiltration
url https://www.tandfonline.com/doi/10.1080/15592294.2023.2276371
work_keys_str_mv AT zhenyilv alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT wenqigao alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT zhiweidu alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT yizheng alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT tianmingliu alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT chenjunhao alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma
AT dongboxue alternativesplicingofirf3playsanimportantroleinthedevelopmentofhepatocarcinoma